Peptides containing the PCNA interacting motif APIM bind to the β-clamp and inhibit bacterial growth and mutagenesis

Nucleic Acids Res. 2020 Jun 4;48(10):5540-5554. doi: 10.1093/nar/gkaa278.

Abstract

In the fight against antimicrobial resistance, the bacterial DNA sliding clamp, β-clamp, is a promising drug target for inhibition of DNA replication and translesion synthesis. The β-clamp and its eukaryotic homolog, PCNA, share a C-terminal hydrophobic pocket where all the DNA polymerases bind. Here we report that cell penetrating peptides containing the PCNA-interacting motif APIM (APIM-peptides) inhibit bacterial growth at low concentrations in vitro, and in vivo in a bacterial skin infection model in mice. Surface plasmon resonance analysis and computer modeling suggest that APIM bind to the hydrophobic pocket on the β-clamp, and accordingly, we find that APIM-peptides inhibit bacterial DNA replication. Interestingly, at sub-lethal concentrations, APIM-peptides have anti-mutagenic activities, and this activity is increased after SOS induction. Our results show that although the sequence homology between the β-clamp and PCNA are modest, the presence of similar polymerase binding pockets in the DNA clamps allows for binding of the eukaryotic binding motif APIM to the bacterial β-clamp. Importantly, because APIM-peptides display both anti-mutagenic and growth inhibitory properties, they may have clinical potential both in combination with other antibiotics and as single agents.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • DNA Polymerase III / antagonists & inhibitors*
  • DNA Polymerase III / chemistry
  • DNA Replication / drug effects
  • DNA-Directed DNA Polymerase
  • Female
  • Methicillin-Resistant Staphylococcus aureus / drug effects
  • Methicillin-Resistant Staphylococcus aureus / genetics
  • Methicillin-Resistant Staphylococcus aureus / growth & development
  • Mice, Inbred BALB C
  • Mutagenesis / drug effects
  • Nucleic Acid Synthesis Inhibitors / chemistry
  • Nucleic Acid Synthesis Inhibitors / pharmacology
  • Nucleic Acid Synthesis Inhibitors / therapeutic use
  • Peptides / chemistry*
  • Peptides / metabolism
  • Peptides / pharmacology*
  • Peptides / therapeutic use
  • Proliferating Cell Nuclear Antigen / metabolism
  • Protein Interaction Domains and Motifs
  • Staphylococcal Skin Infections / drug therapy
  • Staphylococcus epidermidis / drug effects
  • Staphylococcus epidermidis / genetics
  • Staphylococcus epidermidis / growth & development

Substances

  • Anti-Bacterial Agents
  • Nucleic Acid Synthesis Inhibitors
  • Peptides
  • Proliferating Cell Nuclear Antigen
  • beta subunit, DNA polymerase III
  • DNA Polymerase III
  • DNA-Directed DNA Polymerase